Wednesday, December 5, 2012

UM Medicine Rank 38 Nationally for NIH Funding

According to the Blue Ridge Institute for Medical Research, the National Institute of Health (NIH) funding for the UM Miller School totals $117.6M for 2012.  UM has risen 13 spots in just six years and is the only institution in Florida in the top 40.  Ten of the UM's top-funded principal investigators ranked in the top 5% nationally.

None of this is accidental.  Under the leadership of UM President Shalala and Dean Goldschmidt, the focus has been on research in the fields of heart disease, AIDS, diabetes, Alzheimer’s, cancer, paralysis, and a multitude of other diseases and public health issues.  Stem cells, genomics, and robotics are just a few of the tools being used to solve complex questions and changing the way that medical care is delivered.

Top awards:

Jose Szapocznik, Epidemiology and Public Health - $8.42 million
Steven E. Lipshultz, Pediatric Cardiology - $3.86 million
David I. Watkins, Pathology - $3.6 million
Joshua M. Hare, Cardiology and Director of the Interdisciplinary Stem Cell Institute, $2.82 million
Norma Sue Kenyon, Chief Innovation Officer - $2.73 million
Margaret Pericak-Vance, Human Genomics - $2.5 million
Ralph Sacco, Neurology - $2.3 million
Gwendolyn Scott, Pediatrics - $2.16 million
C. Hendricks Brown, Ph.D., Epidemiology - $2.05 million.

Department of Neurological Surgery received $4.2 million in new NIH funding. The department’s W. Dalton Dietrich, the Scientific Director of The Miami Project to Cure Paralysis and Senior Associate Dean for Discovery Science, received $1.5 million.


Miller School’s NIH Funding Climbs to 38th in the Nation